Maintenance Notice (4:30 AM - 11:00 AM December 21, 2024): This website is scheduled to be unavailable due to maintenance. We appreciate your patience and understanding.
Published TCIMAIL newest issue No.197
Maximum quantity allowed is 999
Gelieve het aantal te selecteren
Globo-series Glycosphingolipids
Glycosphingolipids are expressed tissue-specifically and play important roles in cellular processes such as proliferation, migration, senescence, apoptosis and endocytosis. Globo-series glycolipids also have various biological functions, such as O157 Escherichia coli bacterial toxin receptor [Gb3], breast cancer marker [Globo-H], and early embryo-specific antigen‡ [Gb5 (SSEA-3)/Sialyl Gb5 (SSEA-4)]. In addition, globo-series glycolipids are present in human erythrocytes and are antigens of a very rare blood group called P1PK. TCI has a lineup of a variety of globo-series oligosaccharides prepared by chemical synthesis.
‡Early embryo-specific antigen is also called Stage-Specific Embryonic Antigen (SSEA). Glycan structure changes according to the stage of cell differentiation. Therefore, it is used as a marker for iPS cells and human ES cells.1)
Relationship between Globo-series Oligosaccarides and Cancer
The globo-series glycosphingolipids include Gb5 (SSEA-3) and Globo H, which play a role in immune suppression and angiogenesis making them targets for potential new therapies.2,3)
Related Products
Gb3-related Products
- M1767
- Gb3-β-MP
- G0402
- Gb3-β-ethylamine
- G0403
- Gb3-β-ethylazide
- G0479
- Globotriose
- H1718
- HSA-Gb3
- A2506
- Anti-Gb3 Monoclonal Antibody
- A2822
- Anti-Gb3 Monoclonal Antibody Biotin Conjugate
- (* A2506 and A2822 are unavailable in China.)
Gb4-related Products
Forssman-related Products
Gb5 (SSEA-3)-related Products
SialylGb5(SSEA-4)-related Products
Globo-H-related Products
References
- 1) Preimplantation Human Embryos and Embryonic Stem Cells Show Comparable Expression of Stage-Specific Embryonic Antigens
- 2) The role of Globo H and SSEA-4 in the development and progression of cancer, and their potential as therapeutic targets
- 3) Recent advances and future perspectives on carbohydrate-based cancer vaccines and therapeutics
